

HY-75368 · 5 mg
MedChemExpress · Cat: HY-75368
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/sri-31255.html
Description
SRI-31255 is an orally active LRRK2 inhibitor with IC50 values of 520 and 427 nM for human wild-type WT and mutant G2019S, respectively. SRI-31255 exerts neuroprotective effects by binding to the ATP-binding pocket of LRRK2, inhibiting kinase activity. SRI-31255 can be used as a lead compound for the development of LRRK2-targeted drugs for the treatment of Parkinsons disease.







